Noble Wellness Private Limited

Noble Wellness Private Limited is an Indian pharmaceutical company established on April 24, 2012, in New Delhi, Delhi, India. The company is registered under the Corporate Identification Number (CIN) U24232DL2012PTC234745. It operates as a private limited company, classified as a non-government entity, and is unlisted on stock exchanges. The authorized capital stands at ₹0.50 million, with a paid-up capital of ₹0.10 million.

The registered office is located at Dtj810, 8th Floor, DLF Tower-B, DDA District Centre, Jasola, New Delhi, Delhi, 110025. The company specializes in the manufacturing and export of pharmaceutical formulations, including tablets, capsules, syrups, injections, and other dosage forms. Their product portfolio also encompasses herbal formulations, dietary supplements, and nutraceuticals.

Noble Wellness Private Limited operates manufacturing facilities in India, with the registered office situated in New Delhi. While specific details regarding the locations and capacities of their manufacturing plants are not publicly disclosed, the company emphasizes its commitment to quality and compliance with international standards. They hold certifications such as WHO-GMP and ISO, indicating adherence to stringent manufacturing practices.

The leadership team at Noble Wellness Private Limited comprises:

• Archna Ratra: Director since April 24, 2012.
• Sanjay Kumar Ratra: Director since April 24, 2012.

The company does not publicly disclose the positions of Chief Executive Officer (CEO) or Chief Financial Officer (CFO). The directors are actively involved in the company's strategic direction and operations.

Noble Wellness Private Limited's export data indicates shipments to various international markets, including Mongolia, Afghanistan, and China. However, specific regulatory approvals or market access statuses in the United States, European Union, United Kingdom, Australia, and Japan are not publicly available. The company holds WHO-GMP and ISO certifications, which may facilitate entry into certain regulated markets.

The company's export activities in Mongolia, Afghanistan, and China suggest a presence in emerging markets. While specific details regarding WHO prequalification or other certifications enabling access to these markets are not disclosed, the company's adherence to international standards may support its expansion in these regions.

Noble Wellness Private Limited's export data indicates shipments to various international markets, including Mongolia, Afghanistan, and China. However, specific details regarding the company's geographic diversification strategy are not publicly available. The company's focus on international certifications such as WHO-GMP and ISO suggests a strategic direction towards meeting global quality standards.

Specific information regarding FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history for Noble Wellness Private Limited is not publicly available. The company's export data indicates shipments to various international markets, including Mongolia, Afghanistan, and China. However, details regarding FDA approvals or market access are not disclosed.

Noble Wellness Private Limited holds WHO-GMP and ISO certifications, indicating compliance with international manufacturing standards. Specific details regarding EU GMP certificates or EDQM status are not publicly available.

The company is registered with the Ministry of Corporate Affairs under CIN U24232DL2012PTC234745. Specific details regarding CDSCO manufacturing licenses, state drug controller approvals, or export No Objection Certificates (NOCs) are not publicly disclosed.

There are no publicly available records of Form 483 observations, warning letters, or import alerts associated with Noble Wellness Private Limited. The company's adherence to international standards such as WHO-GMP and ISO certifications suggests a commitment to regulatory compliance.

Noble Wellness Private Limited operates in the pharmaceutical manufacturing and export sector, competing with other Indian pharmaceutical companies in the same domain. Specific market share comparisons or head-to-head analyses are not publicly available. The company's focus on international certifications such as WHO-GMP and ISO may provide a competitive edge in global markets.

Noble Wellness Private Limited differentiates itself through its robust portfolio of both prescription and over-the-counter products, including tablets, capsules, syrups, injections, and more. The company also offers a wide range of herbal formulations, dietary supplements, and nutraceuticals. Additionally, their adherence to international standards, as evidenced by WHO-GMP and ISO certifications, underscores their commitment to quality and compliance.

Noble Wellness Private Limited's strategic direction appears to focus on manufacturing and exporting a diverse range of pharmaceutical formulations, including both prescription and over-the-counter products. The company's adherence to international standards such as WHO-GMP and ISO certifications suggests a commitment to quality and regulatory compliance. While specific details regarding future strategic plans are not publicly available, the company's existing certifications and product portfolio position it to cater to both generics and specialty markets.

Noble Wellness Private Limited's export data indicates shipments to various international markets, including Mongolia, Afghanistan, and China. The company's adherence to international standards, as evidenced by WHO-GMP and ISO certifications, suggests a reliable track record in manufacturing and exporting pharmaceutical products. However, specific details regarding export volume consistency and reliability indicators are not publicly available.

Importers should verify the following certifications to ensure product quality and regulatory compliance:

• WHO-GMP Certification: Indicates compliance with World Health Organization Good Manufacturing Practices.
• ISO Certification: Demonstrates adherence to international quality management standards.

These certifications can typically be verified by requesting copies from the supplier or checking with the certifying bodies.

When considering a partnership with Noble Wellness Private Limited, importers should:

• Verify Certifications: Ensure the company holds valid WHO-GMP and ISO certifications.
• Assess Product Portfolio: Review the range and quality of products offered.
• Evaluate Export History: Consider the company's experience and reliability in exporting to various markets.
• Check Regulatory Compliance: Confirm adherence to relevant regulatory standards in target markets.

Red flags to watch for include expired certifications, lack of transparency in operations, or negative feedback from previous partners. Recommended pre-order checks involve requesting product samples, reviewing quality control processes, and conducting background checks on the company's financial stability.